Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
117820172	11782017	2	F	20120621	20160822	20151126	20160822	EXP		DE-BRISTOL-MYERS SQUIBB COMPANY-16956724	BRISTOL MYERS SQUIBB		0.00	DY		F	Y	1.40000	KG	20160822		OT	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
117820172	11782017	1	PS	ATAZANAVIR SULFATE	ATAZANAVIR SULFATE	1	Transplacental	300 MG, QD	364200	MG	U	21567	300	MG	CAPSULE, HARD	QD
117820172	11782017	2	SS	RITONAVIR.	RITONAVIR	1	Transplacental	100 MG, UNK	121400	MG	U	0	100	MG		QD
117820172	11782017	3	C	TRUVADA	EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE	1	Transplacental	200 MG, UNK	1214	MG	U	0	1	DF		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
117820172	11782017	1	Product used for unknown indication
117820172	11782017	2	Product used for unknown indication
117820172	11782017	3	Product used for unknown indication

Outcome of event

Event ID	CASEID	OUTC COD
117820172	11782017	OT

Reactions reported

Event ID	CASEID	PT
117820172	11782017	Foetal exposure during pregnancy
117820172	11782017	Low birth weight baby
117820172	11782017	Premature baby

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
117820172	11782017	1	20090224	20120621
117820172	11782017	2	20090224	20120621
117820172	11782017	3	20090224	20120621